Respiration From Pleth Validation
Part of paid clinical trials in Durham, North Carolina.
- Sponsor
- Philips Clinical & Medical Affairs Global
- Study ID
- NCT07449715
- Status
- Recruiting
Conditions
- Respiratory Rate Monitoring
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Physiological Monitoring with SpO₂ Sensors and Capnography — DEVICEParticipants will undergo noninvasive physiological monitoring with commercially available Philips SpO₂ sensors (adult finger sensor M1191T; pediatric finger glove M1192A; nasal alar sensors 989803205391; adult/pediatric ear sensor M1194A) connected to Philips MP5 or PM6300 patient monitors configured with standard FAST Pulse Oximetry technology. A LoFlo Sidestream etCO₂ sensor (M2741A) with an adult or pediatric oral/nasal cannula (989803206671 or 989803206681) will be used to collect reference capnography waveforms. All monitoring is observational, and no device output is used for clinical decision-making.
Study Details
This observational clinical investigation evaluates the performance of respiratory rate derived from the plethysmography waveform (Respiration from Pleth, RfP) using Philips FAST Pulse Oximetry technology. Adult and pediatric inpatients will undergo noninvasive monitoring using age- and weight-appropriate SpO₂ sensors and capnography, with capnography serving as the reference standard. The study assesses accuracy, mean bias, precision, and time to first valid respiratory-rate value across continuous and spot-check conditions. No device outputs are used for clinical decision-making, and all procedures occur during a single study visit.
Key Dates
- Start date
- Feb 6, 2026
- Status verified
- Feb 2026
- Primary completion
- May 25, 2026
- Completion
- May 25, 2026
Study Design
- Enrollment
- 113 participants (estimated)
Arms
- Arm: Adult InpatientsAdult participants (aged 18 years and older) will undergo noninvasive physiological monitoring using adult-appropriate Philips SpO₂ sensors during a single study visit. Each participant completes two separate 20-minute recording cycles. The first cycle includes simultaneous monitoring with the M1191T adult finger sensor (\>50 kg) and the nasal alar sensor (989803205391; ≥15 kg). The second cycle includes the M1191T adult finger sensor and the M1194A ear sensor (\>40 kg). During both cycles, capnography is recorded concurrently using the LoFlo Sidestream etCO₂ sensor (M2741A) connected to an adult oral/nasal cannula (989803206671). All monitoring is observational, and device outputs are not used for clinical decision-making.
- Arm: Pediatric InpatientsPediatric participants aged 4-17 years receiving physiological monitoring with pediatric-appropriate Philips SpO₂ sensors (M1192A finger glove for 15-50 kg; nasal alar sensors for ≥15 kg; ear sensor M1194A for \>40 kg when age ≥12 years). Participants complete one or two 20-minute recording cycles depending on age/weight per protocol. Capnography is collected using the LoFlo Sidestream etCO₂ sensor with pediatric oral/nasal cannula (989803206681).
Primary Outcome Measure
Respiratory Rate Accuracy (ARMS) - Finger Sensors, Continuous Monitoring [ Time Frame: During the 20-minute continuous monitoring period for the finger sensor. ]
Central Contacts
- Nero Evero, Clinical Study Manager, MS+1 720-201-7689
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke University Hospital | Durham | North Carolina | 27710 | David MacLeod, MBBS (PRINCIPAL_INVESTIGATOR) |